Status:
RECRUITING
A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population
Lead Sponsor:
Cairo University
Conditions:
Laryseal Pro and Ambu Aura Gain as Conduits for Fiberoptic Endotracheal Intubation
Eligibility:
All Genders
4-8 years
Phase:
NA
Brief Summary
This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric popula...
Detailed Description
Airway management is a skill that must be mastered by all anesthesiologists. Since the introduction of the extraglottic airway devices (EADs) in the early 1980s, the EAD has become a central element i...
Eligibility Criteria
Inclusion
- Age starting from 4 years to 8 years.
- Both genders.
- ASA physical status class I-ll.
- Apparently anatomically normal with normal percentile growth chart, not suspected to have difficult airway.
- Scheduled for day case surgeries more than one hour under general anesthesia.
Exclusion
- Parents refusal.
- Abnormality in head and neck or craniofacial anomalies as Piere Robbin syndrome, facial trauma, head and neck tumours, swellings and hemangiomas.
- Patients at risk of regurgitation and pulmonary aspiration such as patients with hiatus hernia, GERD or DM.
- Abnormal or contraindicated cervical spine flexion/extension/rotation.
- Allergy to any EAD components.
- Any active respiratory or cardiac disease and metabolic disorders.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06945029
Start Date
April 15 2025
End Date
April 1 2026
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Cairo University
Cairo, Giza Governorate, Egypt, 1111